Isoniazid (INH) continues to be a highly effective drug in the chemopr
ophylaxis and treatment of tuberculosis; however, its use is associate
d with hepatotoxicity (predominantly hepatic necrosis) in 1-2% of indi
viduals. The INH metabolites, acetylhydrazine and hydrazine, have each
been implicated as the causative hepatotoxin in INH-induced hepatotox
icity. Using a model of INH-induced hepatotoxicity in rabbits, in whic
h INH-induced hepatotoxicity manifests as hepatic necrosis, hepatic st
eatosis (hepatic fat accumulation) and hypertriglyceridaemia (elevated
plasma triglycerides), we compared the severity of these measures of
toxicity with plasma levels of INH, acetylhydrazine and hydrazine. Pla
sma INH and acetylhydrazine were not correlated with markers of INH-in
duced hepatic necrosis or fatty changes. Plasma hydrazine at 32 h was
correlated significantly with plasma argininosuccinic acid lyase (ASAL
, a sensitive marker of hepatic necrosis) activity as area under the c
urve (r(2) = 0.54, P < 0.002) and log plasma ASAL activity at 48 h aft
er the first dose of INH (r(2) = 0.53, p < 0.005), but not with fatty
changes. These results show in this model of INH-induced hepatotoxicit
y in rabbits that hydrazine, and not INH or acetylhydrazine, is most l
ikely involved in the pathogenic mechanism of hepatic necrosis.